SuperworthRevolution Medicines shares outstanding RVMD
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 210.9M
- On a year earlier
- +11.8%
- more shares
Revolution Medicines had 210.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 11.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 194.5M | +12% |
| FY2024 | 174.2M | +23% |
| FY2023 | 141.2M | +58% |
| FY2022 | 89.2M | +21% |
| FY2021 | 73.8M | +11% |
| FY2020 | 66.3M | +2173% |
| FY2019 | 2.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 210.9M | +12% | |
| Q1 FY26 | 198.1M | +5% | |
| Q4 FY25 | 194.5M | +12% | |
| Q3 FY25 | 189.2M | +13% | |
| Q2 FY25 | 188.6M | +14% | |
| Q1 FY25 | 188.1M | +14% | |
| Q4 FY24 | 174.2M | +23% | |
| Q3 FY24 | 166.8M | +53% | |
| Q2 FY24 | 165.1M | +55% | |
| Q1 FY24 | 164.7M | +74% | |
| Q4 FY23 | 141.2M | +58% | |
| Q3 FY23 | 109.2M | +29% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Revolution Medicines
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.